The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
224,000+ research products · Triple ISO certified · COA & SDS available for every product · Same-day shipping on in-stock items
MAP kinase p38 alpha Name And Classification ID: ALA260
Type: SINGLE PROTEIN
Synonyms: 2.7.11.24 | CSAID-binding protein | CSBP | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | Mitogen-activated protein kinase 14 | Mitogen-activated protein kinase p38 alpha | MXI2 | SAPK2A | SAPK2a | Stress-activated protein kinase 2a | Synonyms=CSBP
Organism: Homo sapiens
Species Group: Homo sapiens
Protein Target Classification: Enzyme / Kinase / Protein Kinase / CMGC protein kinase group / CMGC protein kinase MAPK family / CMGC protein kinase p38 subfamily
Target Relations ALA ID Relationship Pref Name Target Type
Target Components Description Relationship Accession Mitogen-activated protein kinase 14 PROTEIN Q16539
Associated Recombinant Proteins Name Specification and purity Expression system Protein label Activity View Details
Associated Antibodies Name Specifications Species reactivity species Application View Details
Associated Active Ligands
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our
Cookie Policy. Settings Agree All Decline
Shall we send you a message when we have discounts available?
Remind me later Allow
Thank you! Please check your email inbox to confirm.
Oops! Notifications are disabled.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
Copyright © 2023–present Aladdin Scientific Corp. All rights reserved.